This chemical is primarily utilized in the synthesis of pharmaceutical compounds. It serves as a key intermediate in the development of active pharmaceutical ingredients (APIs), particularly in the creation of drugs targeting central nervous system disorders. Its trifluoromethoxy group enhances the biological activity and stability of the resulting molecules, making it valuable in medicinal chemistry. Additionally, it is employed in research settings for the design and optimization of novel therapeutic agents, especially those requiring specific electronic and steric properties for effective drug-receptor interactions.